Welshare Health Develops AI-Driven App for Decentralized Medical Research

By Advos

TL;DR

Welshare Health is developing the first decentralized app for AI-driven medical research, giving users more control over their health data.

The app uses DeSci and Web3 technologies to connect patients directly with medical research, using blockchain-based smart contracts for data security.

The app aims to empower individuals to actively participate in medical research, revolutionizing how healthcare is delivered and improving healthcare outcomes.

Welshare Health combines decentralized science and AI to transform patients' lives, giving them more control over their medical issues and becoming active participants in medical research.

Found this article helpful?

Share it with your network and spread the knowledge!

Welshare Health Develops AI-Driven App for Decentralized Medical Research

Welshare Health, a leader in the Decentralized Science (DeSci) space, is developing an innovative application that could transform the landscape of medical research. The company has launched a closed beta version of a decentralized app (dApp) built on Base, which aims to give patients greater control over their health data while allowing them to contribute to medical studies in a personalized manner.

The app, which entered closed beta testing in May 2024, leverages the combined power of AI-driven medical research and Web3 technologies. It addresses significant challenges in traditional medical research, including limited access to diverse datasets and the estimated $600 billion spent annually by medical research companies on data silos due to outdated clinical trial recruitment methods and lack of patient behavior insights.

By eliminating intermediaries and directly connecting patients with medical research, Welshare Health's application tackles the $600 billion health data market problem. The use of blockchain-based smart contracts ensures secure data processing, ownership, and monetization while maintaining privacy. Initially focusing on diabetes research, the app plans to expand into other therapeutic areas.

The potential impact of this technology is significant. For individuals living with type 1 diabetes, the app aims to develop hyper-personalized algorithms that could revolutionize Automated Insulin Delivery (AID) technology. These algorithms would personalize insulin delivery, implement predictive analytics, and integrate with the broader digital health ecosystem.

Welshare Health's approach transforms patients from passive data contributors to active participants in medical research. The app's decentralized governance mechanisms and smart contracts incentivize users to share their data ethically while ensuring fair reward distribution. This model could accelerate medical research, leading to more rapid advancements in healthcare and potentially improving patient outcomes across various medical conditions.

As the healthcare industry increasingly embraces digital technologies and personalized medicine, Welshare Health's initiative represents a significant step towards democratizing medical research and empowering patients. The success of this app could pave the way for similar applications across different areas of healthcare, potentially reshaping the entire medical research landscape.

Curated from BlockchainWire

blockchain registration record for this content
Advos

Advos

@advos